Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced a poster presentation will be featured at the 2026 PEGS Boston Summit, taking place May 11-15 in Boston.